These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21295451)

  • 1. The adverse skeletal effects of selective serotonin reuptake inhibitors.
    Tsapakis EM; Gamie Z; Tran GT; Adshead S; Lampard A; Mantalaris A; Tsiridis E
    Eur Psychiatry; 2012 Apr; 27(3):156-69. PubMed ID: 21295451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?
    Haney EM; Warden SJ; Bliziotes MM
    Bone; 2010 Jan; 46(1):13-7. PubMed ID: 19664737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression.
    Fernandes BS; Hodge JM; Pasco JA; Berk M; Williams LJ
    Drugs Aging; 2016 Jan; 33(1):21-5. PubMed ID: 26547857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis.
    Schweiger JU; Schweiger U; Hüppe M; Kahl KG; Greggersen W; Jauch-Chara K; Fassbinder E
    Int J Environ Res Public Health; 2018 Jun; 15(7):. PubMed ID: 29966324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bones of Contention: A Comprehensive Literature Review of Non-SSRI Antidepressant Use and Bone Health.
    Power C; Duffy R; Mahon J; McCarroll K; Lawlor BA
    J Geriatr Psychiatry Neurol; 2020 Nov; 33(6):340-352. PubMed ID: 31665962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression, selective serotonin reuptake inhibitors, and osteoporosis.
    Bab I; Yirmiya R
    Curr Osteoporos Rep; 2010 Dec; 8(4):185-91. PubMed ID: 20809204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant medications and osteoporosis.
    Rizzoli R; Cooper C; Reginster JY; Abrahamsen B; Adachi JD; Brandi ML; Bruyère O; Compston J; Ducy P; Ferrari S; Harvey NC; Kanis JA; Karsenty G; Laslop A; Rabenda V; Vestergaard P
    Bone; 2012 Sep; 51(3):606-13. PubMed ID: 22659406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P
    Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Serotonin Reuptake Inhibitors (SSRIs) and Markers of Bone Turnover in Men.
    Williams LJ; Berk M; Hodge JM; Kotowicz MA; Stuart AL; Chandrasekaran V; Cleminson J; Pasco JA
    Calcif Tissue Int; 2018 Aug; 103(2):125-130. PubMed ID: 29441424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies.
    Haney EM; Warden SJ
    J Musculoskelet Neuronal Interact; 2008; 8(2):133-45. PubMed ID: 18622082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
    Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
    Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies.
    Wu Q; Bencaz AF; Hentz JG; Crowell MD
    Osteoporos Int; 2012 Jan; 23(1):365-75. PubMed ID: 21904950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis and Fracture Risk Associated with Novel Antidepressants: A Systematic Review and Meta-Analysis.
    Hu J; Xie K; Wu S; Chen Y
    Actas Esp Psiquiatr; 2024 Jun; 52(3):334-346. PubMed ID: 38863057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serotonin reuptake inhibitors may increase the risk of osteoporosis].
    Lerner UH
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2746-9. PubMed ID: 16245546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do SSRIs play a role in decreasing bone mineral density?
    Chen F; Hahn TJ; Weintraub NT
    J Am Med Dir Assoc; 2012 Jun; 13(5):413-7. PubMed ID: 22037240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective serotonin reuptake inhibitor(SSRI)].
    Motohashi N
    Nihon Rinsho; 2001 Aug; 59(8):1519-22. PubMed ID: 11519151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of SSRIs on bone metabolism].
    Kerbage H; Bahadori S; Léger J; Carel JC; Purper Ouakil D
    Encephale; 2014 Feb; 40(1):56-61. PubMed ID: 23810751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function.
    Hodge JM; Wang Y; Berk M; Collier FM; Fernandes TJ; Constable MJ; Pasco JA; Dodd S; Nicholson GC; Kennedy RL; Williams LJ
    Biol Psychiatry; 2013 Jul; 74(1):32-9. PubMed ID: 23260229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modern bioanalytical methods for the rapid detection of antidepressants: SNRIs and SSRIs in human biological samples.
    Samanidou V; Kourti P
    Bioanalysis; 2009 May; 1(2):451-88. PubMed ID: 21083177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.